This protocol is judged by an institutional evaluate board, an unbiased team that critiques any clinical trials involving humans. If a research includes a Program I drug, once the board approves the protocol as moral, the researchers really need to make an application for an investigational new drug (IND) amount through the FDA.Though the protocols